Security Risk Management for Medical Devices: MDR & IVDR Compliance Whitepaper

REPHINE SPEECH MARKS OPEN MEDICALDEVICES

Cybersecurity is no longer a feature—it’s a fundamental aspect of safety, effectiveness, and patient trust. SRM must be integrated from design through decommissioning.

REPHINE SPEECH MARKS CLOSE MEDICALDEVICES

About this Whitepaper

As medical devices become increasingly digital, they face growing exposure to cybersecurity risks—posing potential threats to patient safety and regulatory compliance.

This white paper offers a comprehensive, practical guide to Security Risk Management (SRM) throughout the Total Product Lifecycle (TPLC), covering:

  • Integration of cybersecurity in compliance with EU MDR 2017/745 and IVDR 2017/746
  • Alignment with FDA and IMDRF cybersecurity expectations
  • Use of threat modelling (STRIDE) and SBOMs for risk analysis
  • Security V&V activities including penetration testing and vulnerability scanning
  • Postmarket risk management and coordinated vulnerability disclosure

Whether you’re preparing a technical file, improving postmarket surveillance, or building secure-by-design software, this guide helps ensure your devices meet state-of-the-art standards like IEC 81001-5-1 and stay compliant with international regulations.

Who Should Read This?

  • Medical Device Regulatory & QA Professionals

  • Product Development & Cybersecurity Teams

  • Design Engineers & Risk Managers

  • EU MDR / IVDR Compliance Officers

Hero Image Software Testing Guide MedTech

View our other resources and company news

QMS IMP Header image case study May 25 Article

How an Internal Services Audit Can Maximise Your Regulatory Compliance

Internal services audits play a critical role in maintaining GMP compliance and driving continuous improvement. This article explores how structured gap assessments, internal audits and ...
Read More
GMP Raising the bar Blog series Header image May 25 Article

Effective QMS Management Post-Go-Live: Strategies for Governance, Releases, and Continuous Improvement

After QMS go live, compliance and performance depend on strong governance, structured release management and continuous improvement. Learn how to sustain control, adoption and long ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan Case Study

GMP Consultancy for a New Manufacturing Plant

With only a small team and a highly automated process, this biotech company needed to achieve EU GMP compliance fast. This case study shows how ...
Read More
ICH E6 Guide Header Image (1500 x 844 px) Article

Why Quality Can No Longer Live in Silos

Discover why siloed quality management is no longer sustainable in life sciences. Learn how integrating audits, advisory services and digital quality systems supports continuous GxP ...
Read More
QMS IMP Header image Blog case study May 25 Article

Why Most QMS Implementations Fail to Deliver Long-Term Value

Implementing a QMS is more than deploying software. Learn why most QMS implementations fall short, and what successful life sciences teams do differently to achieve ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan Case Study

Driving Global QMS Harmonisation for a Pharmaceutical Company

This case study outlines how Rephine helped a global pharmaceutical group implement and validate a harmonised Quality Management System across more than seventy sites. It ...
Read More
CSV Blog

IT Quality Assurance in Regulated Life Sciences: Key Insights

IT Quality Assurance is pivotal in regulated life sciences. From CSV and data integrity to change control and audit readiness, discover how IT QA ensures ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan General

Practical compliance and inspection readiness for UK pharmaceutical quality systems

Explore how UK pharmaceutical and biotech organisations can stay prepared for MHRA, EMA and FDA inspections. This session provides expert guidance on inspection trends, compliance ...
Read More
BANNER Practical Guide to Post Market Surveillance PMS under EU MDR IVDR CSV

Practical Guide to the EMA’s Draft EU GMP Revisions

The EU’s new Product Liability Directive (2024/2853) changes who can be held liable and what damages can be claimed. From software and data loss to ...
Read More
Contact Us

Strengthen Your Assurance Journey

GMP Chapter 22 Adapting to Hybrid Documentation Standards